Tiziana Life Sciences Ltd (FRA:0RP)
1.540
+0.010 (0.65%)
At close: Nov 28, 2025
Tiziana Life Sciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 7.25 | 3.72 | 1.18 | 18.12 | 42.19 | 65.82 | Upgrade |
Cash & Short-Term Investments | 7.25 | 3.72 | 1.18 | 18.12 | 42.19 | 65.82 | Upgrade |
Cash Growth | 541.68% | 214.79% | -93.47% | -57.04% | -35.91% | 32812.00% | Upgrade |
Accounts Receivable | - | - | - | - | - | 0.15 | Upgrade |
Other Receivables | 4.95 | 3.64 | 5.93 | 5.86 | 5.27 | 3.5 | Upgrade |
Receivables | 4.95 | 3.64 | 5.93 | 5.86 | 5.27 | 3.65 | Upgrade |
Prepaid Expenses | 0.52 | 0.09 | 0.1 | 0.17 | 1.19 | 0.38 | Upgrade |
Other Current Assets | - | 0.05 | 0.12 | 0.13 | 0.04 | 0.33 | Upgrade |
Total Current Assets | 12.72 | 7.51 | 7.34 | 24.28 | 48.68 | 70.18 | Upgrade |
Property, Plant & Equipment | 0.15 | 0.19 | 0.29 | 0.39 | 0.02 | 0.36 | Upgrade |
Long-Term Investments | 3.73 | 3.59 | 4.55 | 1.81 | - | - | Upgrade |
Other Intangible Assets | - | - | - | - | 0.13 | 0.12 | Upgrade |
Total Assets | 16.6 | 11.28 | 12.18 | 26.48 | 48.83 | 70.66 | Upgrade |
Accounts Payable | 7.18 | 5.58 | 4.14 | 4.96 | 4.41 | 3.37 | Upgrade |
Accrued Expenses | - | 1.65 | 2.25 | 1.57 | 1.78 | 2.22 | Upgrade |
Current Portion of Leases | 0.11 | 0.11 | 0.14 | 0.12 | - | 0.27 | Upgrade |
Other Current Liabilities | 0.01 | 0.01 | 0.01 | 0.01 | 1.37 | 2.13 | Upgrade |
Total Current Liabilities | 7.4 | 7.35 | 6.54 | 6.66 | 7.55 | 7.98 | Upgrade |
Long-Term Leases | - | - | 0.11 | 0.24 | - | 0.29 | Upgrade |
Total Liabilities | 7.4 | 7.35 | 6.65 | 6.91 | 7.55 | 8.27 | Upgrade |
Common Stock | 0.12 | 0.11 | 0.1 | 0.1 | 0.1 | 0.1 | Upgrade |
Additional Paid-In Capital | 31.79 | 23.11 | 16.49 | 15.6 | 15.6 | - | Upgrade |
Retained Earnings | -150.46 | -144.83 | -133.68 | -116.26 | -108.06 | -84.65 | Upgrade |
Treasury Stock | - | - | -1.57 | -1.32 | - | - | Upgrade |
Comprehensive Income & Other | 127.76 | 125.55 | 124.19 | 121.46 | 133.65 | 146.94 | Upgrade |
Shareholders' Equity | 9.2 | 3.94 | 5.54 | 19.57 | 41.28 | 62.39 | Upgrade |
Total Liabilities & Equity | 16.6 | 11.28 | 12.18 | 26.48 | 48.83 | 70.66 | Upgrade |
Total Debt | 0.11 | 0.11 | 0.25 | 0.37 | - | 0.56 | Upgrade |
Net Cash (Debt) | 7.14 | 3.62 | 0.94 | 17.76 | 42.19 | 65.27 | Upgrade |
Net Cash Growth | 651.21% | 286.54% | -94.73% | -57.91% | -35.37% | - | Upgrade |
Net Cash Per Share | 0.06 | 0.03 | 0.01 | 0.17 | 0.43 | 0.67 | Upgrade |
Filing Date Shares Outstanding | 118.82 | 111.46 | 101.51 | 100.59 | 102.27 | 194.61 | Upgrade |
Total Common Shares Outstanding | 118.82 | 111.46 | 101.51 | 100.59 | 102.27 | 194.61 | Upgrade |
Working Capital | 5.32 | 0.16 | 0.8 | 17.62 | 41.13 | 62.2 | Upgrade |
Book Value Per Share | 0.08 | 0.04 | 0.05 | 0.19 | 0.40 | 0.32 | Upgrade |
Tangible Book Value | 9.2 | 3.94 | 5.54 | 19.57 | 41.15 | 62.27 | Upgrade |
Tangible Book Value Per Share | 0.08 | 0.04 | 0.05 | 0.19 | 0.40 | 0.32 | Upgrade |
Machinery | - | - | - | - | - | 0.06 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.